MENU
CING
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Cingulate (CING) Earnings Date & Reports

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes... Show more

A.I. Advisor
published Earnings

CING is expected to report earnings to fall 7.50% to -555 cents per share on March 08

Cingulate CING Stock Earnings Reports
Q4'23
Est.
$-5.55
Q3'23
Beat
by $1.40
Q2'23
Missed
by $11.05
Q1'23
Missed
by $6.68
Q4'22
Missed
by $7.83
The last earnings report on November 13 showed earnings per share of -600 cents, beating the estimate of -740 cents. With 56.82K shares outstanding, the current market capitalization sits at 15.87M.
View a ticker or compare two or three
CING
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1901 West 47th Place
Phone
+1 913 942-2300
Employees
13
Web
https://www.cingulate.com